Fat Compartments and Apolipoprotein B‐100 Kinetics in Overweight‐Obese Men
- 1 January 2003
- journal article
- Published by Wiley in Obesity Research
- Vol. 11 (1) , 152-159
- https://doi.org/10.1038/oby.2003.24
Abstract
To examine the association between the kinetics of very-low-density-lipoprotein (VLDL)-apolipoprotein B-100 (apoB) and intraperitoneal, retroperitoneal, subcutaneous abdominal, and total adipose tissue masses (IPATM, RPATM, SAATM, and TATM, respectively) in overweight/obese men. Hepatic secretion of VLDL was measured using an intravenous infusion of 1-[(13)C]-leucine in 51 men with a wide range of body mass index (25.1 to 42.2 kg/m(2)). Isotopic enrichment of VLDL-apoB was measured using gas chromatography-mass spectrometry and a multicompartmental model used to estimate VLDL-apoB metabolic parameters. IPATM, RPATM, and SAATM (kilograms) were quantified between T11 and S1 using magnetic resonance imaging; TATM (kilograms) was determined using bioelectrical impedance. Insulin resistance was estimated by homeostasis model assessment (HOMA) score. In stepwise regression, IPATM was the best predictor of hepatic secretion of VLDL-apoB (r = 0.390, p < 0.005) and TATM was the best predictor of VLDL-apoB fractional catabolic rate (r = 0.282, p < 0.05). IPATM remained significantly associated with VLDL-apoB secretion after adjusting for TATM or HOMA score (r = 0.360, p < 0.01 and r = 0.310, p < 0.05, respectively). This association was also independent of age, dietary intake, and body mass index. None of the fat compartments were significantly associated with the fractional catabolic rate of VLDL-apoB after adjusting for HOMA score. In overweight/obese men, the quantity of both IPATM and TATM determine the kinetics of VLDL-apoB. The effect of IPATM on VLDL-apoB secretion is independent of both total fat mass and the degree of insulin resistance.Keywords
This publication has 40 references indexed in Scilit:
- Reduction in Visceral Adipose Tissue Is Associated with Improvement in Apolipoprotein B-100 Metabolism in Obese MenJournal of Clinical Endocrinology & Metabolism, 1999
- Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesityInternational Journal of Obesity, 1998
- Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal MenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Relationship of Anterior and Posterior Subcutaneous Abdominal Fat to Insulin Sensitivity in Nondiabetic MenObesity Research, 1997
- Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.Journal of Clinical Investigation, 1995
- Comparison of immunoturbidimetric and Lowry methods for measuring concentration of very low density lipoprotein apolipoprotein B-100 in plasma.Journal of Clinical Pathology, 1994
- Substrate delivery as a determinant of hepatic apoB secretion.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Splanchnic insulin metabolism in obesity. Influence of body fat distribution.Journal of Clinical Investigation, 1986
- Comparisons of metabolism of apolipoprotein B in normal subjects, obese patients, and patients with coronary heart disease.Journal of Clinical Investigation, 1985
- Role of insulin resistance in adipose tissue and liver in the pathogenesis of endogenous hypertriglyceridaemia in manDiabetologia, 1976